During the past decade, Palo Alto Medical Foundation-Santa Cruz conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 50 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 47 clinical trials were completed. i.e. 247.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palo Alto Medical Foundation-Santa Cruz" #1 sponsor was "National Cancer Institute (NCI)" with 56 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "GOG Foundation" with 6 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation-Santa Cruz" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation-Santa Cruz" are "Invasive Breast Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Recurrent Fallopian Tube Carcinoma" (7 trials), "Recurrent Primary Peritoneal Carcinoma" (7 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Palo Alto Medical Foundation-Santa Cruz" in a lesser frequency.

Most popular intervention types in "Palo Alto Medical Foundation-Santa Cruz" are "Drug" (88 trials), "Other" (74 trials), "Biological" (46 trials), "Procedure" (29 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (32 trials), "Computed Tomography" (17 trials), "Paclitaxel" (15 trials) and "Biospecimen Collection" (14 trials). Other intervention names were less common.

The vast majority of trials in "Palo Alto Medical Foundation-Santa Cruz" are 80 trials for "All" genders, 29 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Palo Alto Medical Foundation-Santa Cruz". undefined are not yet recruiting, 21 are recruiting, 67 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Palo Alto Medical Foundation-Santa Cruz, 3 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Palo Alto Medical Foundation-Santa Cruz, 2 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".